SOD2 and Alzheimer disease: MnSOD expression is also increased via SIRT3 activation in amyloid-beta (Aβ)-treated models, where a novel rhamnoside derivative reduced ROS, restored mitochondrial integrity, and suppressed cellular senescence, reinforcing the MnSOD–SIRT3 axis as a promising neuroprotective pathway in AD [220].